5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Por um escritor misterioso
Descrição
Niemann–Pick is a rare autosomal recessive inherited disease that is characterized by excessive accumulation of cholesterol and lipids in cells, leading to apoptosis and neural degeneration. The disease affects numerous body parts such as the brain, nerves, liver, spleen, bone marrow and lungs. Those suffering from the disease suffer from lack of coordination, dystonia; sleep disturbances, difficult in eating and swallowing and frequent bouts of pneumonia.
Orphazyme sells entire business to US biotech company — MedWatch
2022 drug approvals: Biopharma delivered 34 new drugs
Niemann–Pick disease, type C - Wikipedia
Ohio 2-year-old battling rare Niemann-Pick disease, dubbed 'childhood Alzheimer's
Researchers Study Ebola Link to Gene in Rare Disease - WSJ
Lynbrook family hopes to give dying child a lifetime of memories - Newsday
PDF) Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier: Molecular Therapy
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/7wl0X.jpg)
